Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-03-03

Clinical Trial Update: Use of Etanercept in the Treatment of Moderate to Severe Lichen Planus [Phase 2]

View source ↗

Summary

Phase 2 study evaluating etanercept for moderate to severe lichen planus was terminated. Results were posted in 2015.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Etanercept (etanercept)

Snippet

Sponsor: Stanford University | Conditions: Lichen Planus | Phase 2 | Status: TERMINATED | Results posted: 2015-03-03